By Professor Kei Lui

Preprints

Stiboy E; Chan M; Islam MS; L GS; Lui K; Jaffe A; Homaira N, 2022, Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants, http://dx.doi.org/10.22541/au.166419726.62754781/v1

Gurumahan V; Thavalingam S; Schindler T; Smyth J; Lui K; Bolisetty S, 2022, Reference Values For Diaphragm Electrical Activity (Edi) In Newborn Infants, http://dx.doi.org/10.21203/rs.3.rs-1387574/v1

Stiboy E; Chan M; Islam MS; L GS; Lui K; Jaffe A; Homaira N, 2022, Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants, http://dx.doi.org/10.22541/au.166419726.62754781/v2

Gurumahan V; Thavalingam S; Schindler T; Smyth J; Lui K; Bolisetty S, 2021, Reference values for diaphragm electrical activity (Edi) in newborn infants, http://dx.doi.org/10.22541/au.162514165.52117415/v1

Back to profile page